Isil Bulur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Isil Bulur has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Zeynep Nurhan Saracoglu
Department of Dermatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
6 shared publicationsTekden Karapınar
Department of Dermatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
4 shared publications- Evrim Yılmaz
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ, TIP FAKÜLTESİ
3 shared publications Hilal Gokalp
3 shared publicationsHilal Kaya Erdoğan
Department of Dermatology and Venereology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
3 shared publications- Hilal Kaya Erdoğan
Department of Dermatology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
3 shared publications
Latest Publications
- 1 December 2018
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 12 (4) , 172-176
Evaluation of the Relationship Between T Regulatory Cells and Vitamin D Levels in Chronic Spontaneous Urticaria
- 1 December 2018
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 12 (4) , 172-176
Evaluation of the Relationship Between T Regulatory Cells and Vitamin D Levels in Chronic Spontaneous Urticaria
- 1 May 2018
- Published by Edizioni Minerva Medica in Italian Journal of Dermatology and Venereology
- Vol. 153 (4) , 477-482
The role of irisin in the relationship between psoriasis and insulin resistance
Irisin, a hormone like myokine, is identified to the relation with insulin resistance and metabolic syndrome recently. In the literature to date, there are no studies evaluating serum irisin levels in psoriasis patients. We aimed to elucidate the pathogenesis of insulin resistance in psoriasis patients by evaluating serum irisin levels and metabolic parameters associated with insulin resistance in patients with plaque-type psoriasis vulgaris. The study included 40 patients with moderate-to-severe chronic plaque-type psoriasis vulgaris and 37 healthy subjects. Body Mass Index (BMI) and waist circumference were measured, and serum irisin, fasting blood glucose (FBG), lipid profile, high-sensitivity CRP (hs-CRP) and insulin levels were assessed. To evaluate insulin resistance, the Homeostasis Model Assessment (HOMA-IR) and triglyceride/HDL (TG/HDL) ratio were used. Serum irisin and HDL levels were significantly lower in patients than the control group (P<0.001, P=0.024). Within the patient group, there was a significant negative correlation between serum irisin and serum TG, LDL, and TG/HDL levels (P=0.041, P=0.022, P=0.025), and a positive correlation with HDL levels (P=0.036). The PASI scores and serum irisin levels were significantly positively correlated. In conclusion, we observed that serum irisin levels were significantly lower in patients with psoriasis, and associated with serum lipid levels and disease activity in our study. These results can be interpreted that irisin is involved in the disease pathogenesis of patients with psoriasis in relation to metabolic dysregulation.
- 1 May 2018
- Published by Edizioni Minerva Medica in Italian Journal of Dermatology and Venereology
- Vol. 153 (4) , 477-482
The role of irisin in the relationship between psoriasis and insulin resistance
Irisin, a hormone like myokine, is identified to the relation with insulin resistance and metabolic syndrome recently. In the literature to date, there are no studies evaluating serum irisin levels in psoriasis patients. We aimed to elucidate the pathogenesis of insulin resistance in psoriasis patients by evaluating serum irisin levels and metabolic parameters associated with insulin resistance in patients with plaque-type psoriasis vulgaris. The study included 40 patients with moderate-to-severe chronic plaque-type psoriasis vulgaris and 37 healthy subjects. Body Mass Index (BMI) and waist circumference were measured, and serum irisin, fasting blood glucose (FBG), lipid profile, high-sensitivity CRP (hs-CRP) and insulin levels were assessed. To evaluate insulin resistance, the Homeostasis Model Assessment (HOMA-IR) and triglyceride/HDL (TG/HDL) ratio were used. Serum irisin and HDL levels were significantly lower in patients than the control group (P<0.001, P=0.024). Within the patient group, there was a significant negative correlation between serum irisin and serum TG, LDL, and TG/HDL levels (P=0.041, P=0.022, P=0.025), and a positive correlation with HDL levels (P=0.036). The PASI scores and serum irisin levels were significantly positively correlated. In conclusion, we observed that serum irisin levels were significantly lower in patients with psoriasis, and associated with serum lipid levels and disease activity in our study. These results can be interpreted that irisin is involved in the disease pathogenesis of patients with psoriasis in relation to metabolic dysregulation.
- Open Access
- 1 February 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (1) , 33-38
The efficacy and safety of phototherapy in geriatric patients: a retrospective study
Keywords: Health of the elderly; Phototherapy; Skin diseases
- 1 February 2018
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 93 (1) , 33-38
Open AccessThe efficacy and safety of phototherapy in geriatric patients: a retrospective study
Keywords: Health of the elderly; Phototherapy; Skin diseases
- 30 September 2017
- Published by Association of Slovenian Dermatovenerologists in Acta Dermatovenerologica Alpina Pannonica et Adriatica
- Vol. 26 (3) , 69-71
Kaposi’s sarcoma concealed by stasis dermatitis in a patient with psoriasis
Kaposi's sarcoma (KS) is a multifocal and angioproliferative neoplasm. KS may be accompanied by psoriasis; however, in most of these cases the main mechanism involves iatrogenic KS associated with the immunosuppressive drugs that are used in psoriasis treatment. In angioproliferative lesions as a result of venous insufficiency and stasis dermatitis, acroangiodermatitis (pseudo-KS) is initially considered. However, the concurrent occurrence of psoriasis, stasis dermatitis, and KS has not been previously reported. We report a case of classic-type KS in an 83-year-old man that was concealed by stasis dermatitis and accompanied by psoriasis.
- 30 September 2017
- Published by Association of Slovenian Dermatovenerologists in Acta Dermatovenerologica Alpina Pannonica et Adriatica
- Vol. 26 (3) , 69-71
Kaposi’s sarcoma concealed by stasis dermatitis in a patient with psoriasis
Kaposi's sarcoma (KS) is a multifocal and angioproliferative neoplasm. KS may be accompanied by psoriasis; however, in most of these cases the main mechanism involves iatrogenic KS associated with the immunosuppressive drugs that are used in psoriasis treatment. In angioproliferative lesions as a result of venous insufficiency and stasis dermatitis, acroangiodermatitis (pseudo-KS) is initially considered. However, the concurrent occurrence of psoriasis, stasis dermatitis, and KS has not been previously reported. We report a case of classic-type KS in an 83-year-old man that was concealed by stasis dermatitis and accompanied by psoriasis.
- 1 September 2017
- Published by Elsevier in Clinics in Dermatology
- Vol. 35 (5) , 421-434
Behçet disease: New aspects
- 1 September 2017
- Published by Elsevier in Clinics in Dermatology
- Vol. 35 (5) , 421-434
Behçet disease: New aspects
- Open Access
- 31 May 2017
- Published by IntechOpen
Contact Urticaria
Contact Urticaria | InTechOpen, Published on: 2017-05-31. Authors: Isil Bulur and Hilal Gokalp
- 31 May 2017
- Published by IntechOpen
Open AccessContact Urticaria
Contact Urticaria | InTechOpen, Published on: 2017-05-31. Authors: Isil Bulur and Hilal Gokalp
- Open Access
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 4 (4) , 334-338
Morphea in Middle Anatolia, Turkey: a 5-year single-center experience
Introduction: Morphea, also referred to as localized scleroderma, is a rare fibrosing skin disorder of undetermined cause. Aim: We report our single-center experience with morphea. Material and methods: The study included 53 patients who were diagnosed with morphea by...
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 4 (4) , 334-338
Open AccessMorphea in Middle Anatolia, Turkey: a 5-year single-center experience
Introduction: Morphea, also referred to as localized scleroderma, is a rare fibrosing skin disorder of undetermined cause. Aim: We report our single-center experience with morphea. Material and methods: The study included 53 patients who were diagnosed with morphea by...
- Open Access
- 1 January 2017
- Published by Medknow in Indian Journal of Dermatology
- Vol. 62 (4) , 440
Superimposed segmental manifestation of juvenile amyopathic dermatomyositis in a 9-year-old boy
Dermatomyositis is a well-known autoimmune disorder. On the other hand, juvenile amyopathic dermatomyositis (JADM) occurs rather rarely. Here, we report an unusual case in a 9-year-old Turkish boy showing a unilateral linear inflammatory skin lesion that was followed, after 16 months, by the appearance of bilateral disseminated features JADM.
- 1 January 2017
- Published by Medknow in Indian Journal of Dermatology
- Vol. 62 (4) , 440
Open AccessSuperimposed segmental manifestation of juvenile amyopathic dermatomyositis in a 9-year-old boy
Dermatomyositis is a well-known autoimmune disorder. On the other hand, juvenile amyopathic dermatomyositis (JADM) occurs rather rarely. Here, we report an unusual case in a 9-year-old Turkish boy showing a unilateral linear inflammatory skin lesion that was followed, after 16 months, by the appearance of bilateral disseminated features JADM.
- 4 November 2016
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 16 (4) , 485-490
Evaluation of the effects of acne vulgaris on quality of life in Turkey by using TAQLI
Acne vulgaris (AV) is a chronic, inflammatory skin disease that may cause various psychiatric and/or psychological problems. In this study, we aimed to determine the effect of AV on the quality of life in the Turkish population using the Turkish Acne Quality of Life Index (TAQLI). A total of 960 patients with AV who attended the dermatology department were included in the study. Acne severity was determined using the global acne classification system. TAQLI was used to evaluate the effect of acne on quality of life. The 960 patients consisted of 673 (70.1%) females and 287 (29.9%) males. There were 536 (55.8%) patients under the age of 20, 386 (40.2%) aged 20–30, and 38 (4.0%) over 30. Acne duration varied between 1 and 20 years, and the mean duration was 2.95 ± 2.53 years. The mean TAQLI value of all patients was 20.8 ± 9.5. The mean TAQLI value was statistically significantly higher in female patients, in patients with an acne duration of more than 2 years, and in those with very severe acne. However, no statistically significant difference was found between the age groups. We observed that the quality of life in patients with AV was affected, and this effect was more significant in female patients, patients with severe acne and longer acne duration. We believe that the psychiatric/psychological effects should be followed up closely in this group of patients.
- 4 November 2016
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 16 (4) , 485-490
Evaluation of the effects of acne vulgaris on quality of life in Turkey by using TAQLI
Acne vulgaris (AV) is a chronic, inflammatory skin disease that may cause various psychiatric and/or psychological problems. In this study, we aimed to determine the effect of AV on the quality of life in the Turkish population using the Turkish Acne Quality of Life Index (TAQLI). A total of 960 patients with AV who attended the dermatology department were included in the study. Acne severity was determined using the global acne classification system. TAQLI was used to evaluate the effect of acne on quality of life. The 960 patients consisted of 673 (70.1%) females and 287 (29.9%) males. There were 536 (55.8%) patients under the age of 20, 386 (40.2%) aged 20–30, and 38 (4.0%) over 30. Acne duration varied between 1 and 20 years, and the mean duration was 2.95 ± 2.53 years. The mean TAQLI value of all patients was 20.8 ± 9.5. The mean TAQLI value was statistically significantly higher in female patients, in patients with an acne duration of more than 2 years, and in those with very severe acne. However, no statistically significant difference was found between the age groups. We observed that the quality of life in patients with AV was affected, and this effect was more significant in female patients, patients with severe acne and longer acne duration. We believe that the psychiatric/psychological effects should be followed up closely in this group of patients.
- 22 January 2016
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 38
KUTANÖZ ÜLSERLER ?LE SEYREDEN AKUT METOTREKSAT TOKS?S?TES? / ACUTE METHOTREXATE TOXICITY PRESENTING WITH CUTANEOUS ULCERATIONS
Özet: Psoriazis eritemli, skuamlı ve endure plaklarla karakterize, en sık saçlı deri ve ekstansör yüzeyleri tutan kronik bir dermatozdur. Metotreksat psoriazis tedavisinde yaygın kullanılan sentetik bir folik asit analoğudur. Kanda nadiren toksik düzeylere ulaşarak şiddetli yan etkilere sebep olur. Bu durumda akut dönemde psoriatik plaklarda ülserasyon ve nekrozla karakterize cilt bulguları ortaya çıkar. Çoğu olguda sebep, ilacın yanlışlıkla haftalık rejim yerine daha kısa sürelerde veya bir defada çok miktarda alınmasıdır. Eşlik eden ileri yaş ve renal yetmezlik gibi nedenler de toksisiteye katkıda bulunur. Metotreksat toksisitesini erken dönemde tanımak ve hemen tedaviye başlamak açısından kutanöz bulgular oldukça önemlidir. Burada kliniğimize başvuran bir olgudan hareketle akut metotreksat toksisitesine yaklaşım ele alınacaktır. Anahtar Sözcükler: kutanöz ülser, metotreksat, psoriazis ACUTE METHOTREXATE TOXICITY PRESENTING WITH CUTANEOUS ULCERATIONS Abstract: Psoriasis is a chronic dermatosis characterized by erythematosus, scaly and indurated plaques which are most often located on scalp and extensor surfaces. Methotrexate is a synthetic folic asid analogue which is commonly used for the treatment of psoriasis. It rarely reaches toxic levels in the blood and causes severe adverse effects. In this situation, skin findings characterized by ulcerations and necrosis on psoriatic plaques emerge at the acute stage. In the most of the cases, the reason is misuse of the drug which is taking medicine at short intervals or too much during a treatment session instead of weekly regimen. Additional causes such as renal failure and older age contribute toxicity. Cutaneous findings are quite important to recognize methotrexate toxicity at the early stages and to start the treatment immediately. Herein, the approach to acute methotrexate toxicity will be discussed with reference to a case that is referred to our clinic. Key Words: cutaneous ulceration, methotrexate, psoriasis
- 22 January 2016
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 38
KUTANÖZ ÜLSERLER ?LE SEYREDEN AKUT METOTREKSAT TOKS?S?TES? / ACUTE METHOTREXATE TOXICITY PRESENTING WITH CUTANEOUS ULCERATIONS
Özet: Psoriazis eritemli, skuamlı ve endure plaklarla karakterize, en sık saçlı deri ve ekstansör yüzeyleri tutan kronik bir dermatozdur. Metotreksat psoriazis tedavisinde yaygın kullanılan sentetik bir folik asit analoğudur. Kanda nadiren toksik düzeylere ulaşarak şiddetli yan etkilere sebep olur. Bu durumda akut dönemde psoriatik plaklarda ülserasyon ve nekrozla karakterize cilt bulguları ortaya çıkar. Çoğu olguda sebep, ilacın yanlışlıkla haftalık rejim yerine daha kısa sürelerde veya bir defada çok miktarda alınmasıdır. Eşlik eden ileri yaş ve renal yetmezlik gibi nedenler de toksisiteye katkıda bulunur. Metotreksat toksisitesini erken dönemde tanımak ve hemen tedaviye başlamak açısından kutanöz bulgular oldukça önemlidir. Burada kliniğimize başvuran bir olgudan hareketle akut metotreksat toksisitesine yaklaşım ele alınacaktır. Anahtar Sözcükler: kutanöz ülser, metotreksat, psoriazis ACUTE METHOTREXATE TOXICITY PRESENTING WITH CUTANEOUS ULCERATIONS Abstract: Psoriasis is a chronic dermatosis characterized by erythematosus, scaly and indurated plaques which are most often located on scalp and extensor surfaces. Methotrexate is a synthetic folic asid analogue which is commonly used for the treatment of psoriasis. It rarely reaches toxic levels in the blood and causes severe adverse effects. In this situation, skin findings characterized by ulcerations and necrosis on psoriatic plaques emerge at the acute stage. In the most of the cases, the reason is misuse of the drug which is taking medicine at short intervals or too much during a treatment session instead of weekly regimen. Additional causes such as renal failure and older age contribute toxicity. Cutaneous findings are quite important to recognize methotrexate toxicity at the early stages and to start the treatment immediately. Herein, the approach to acute methotrexate toxicity will be discussed with reference to a case that is referred to our clinic. Key Words: cutaneous ulceration, methotrexate, psoriasis